Evidence map›Paper›PMID 37973897›Full record

ArticleNature metabolism2023

Vitamin B

Marta Kovatcheva, Elena Melendez, Dafni Chondronasiou, Federico Pietrocola, Raquel Bernad, Adrià Caballe, Alexandra Junza, Jordi Capellades, Adrián Holguín-Horcajo, Neus Prats and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Nature metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Vitamin BNature communications · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Vitamin BResearch square · 2025
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 4 countries.

Marta KovatchevaInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. marta.kovatcheva@irbbarcelona.org.ORCID 0000-0002-2536-1043
Elena MelendezInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.ORCID 0000-0002-5584-1179
Dafni ChondronasiouInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Federico PietrocolaInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Raquel BernadInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.ORCID 0000-0002-9003-1323
Adrià CaballeInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.ORCID 0000-0002-2388-4713
Alexandra JunzaUniversitat Rovira i Virgili, Department of Electronic Engineering, IISPV, Tarragona, Spain.
Jordi CapelladesUniversitat Rovira i Virgili, Department of Electronic Engineering, IISPV, Tarragona, Spain.
Adrián Holguín-HorcajoDepartment of Physiological Science, School of Medicine, Universitat de Barcelona (UB), L'Hospitalet de Llobregat, Spain.ORCID 0000-0002-5447-6181
Neus PratsInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Sylvere DurandMetabolomics and Cell Biology Platforms UMS AMMICa/UMR 1138, Institut Gustave Roussy, Villejuif, France.
Meritxell RoviraDepartment of Physiological Science, School of Medicine, Universitat de Barcelona (UB), L'Hospitalet de Llobregat, Spain.ORCID 0000-0002-0538-4846
Oscar YanesUniversitat Rovira i Virgili, Department of Electronic Engineering, IISPV, Tarragona, Spain.ORCID 0000-0003-3695-7157
Camille Stephan-Otto AttoliniInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.ORCID 0000-0001-8045-320X
Guido KroemerMetabolomics and Cell Biology Platforms UMS AMMICa/UMR 1138, Institut Gustave Roussy, Villejuif, France.ORCID 0000-0002-9334-4405
Manuel SerranoInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. mserrano@altoslabs.com.ORCID 0000-0001-7177-9312
Institute for Research in Biomedicine · ESInserm · FRInstitut d'Investigació Biomédica de Bellvitge · ESInstituto de Salud Carlos III · ESInstitució Catalana de Recerca i Estudis Avançats · ESInstitut de Recerca Biomèdica Catalunya Sud · ESKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transient reprogramming by the expression of OCT4, SOX2, KLF4 and MYC (OSKM) is a therapeutic strategy for tissue regeneration and rejuvenation, but little is known about its metabolic requirements. Here we show that OSKM reprogramming in mice causes a global depletion of vitamin B

Indexed as

Cell PlasticityCellular ReprogrammingAnimalsMiceVitamin B 12VitaminsWound HealingVitamin B 12Vitamins

Identifiers

PMID37973897
PMCPMC10663163
OpenAlexW4388734396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.